Baseline and Post-treatment 18F-Fluorocholine PET/CT Predicts Outcomes in Hepatocellular Carcinoma Following Locoregional Therapy-Reference-Cited by-同舟云学术

Baseline and Post-treatment 18F-Fluorocholine PET/CT Predicts Outcomes in Hepatocellular Carcinoma Following Locoregional Therapy

Published:2019-08-22 Issue:2 Volume:65 Page:647-657
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Wallace Michael C.^ORCID,Sek Kenny,Francis Roslyn J.,Samuelson Shaun,Ferguson John,Tibballs Jonathan,Asad Ali,Preen David B.,MacQuillan Gerry,Garas George,Adams Leon A.,Jeffrey Gary P.

Funder

Cancer and Palliative Care Research and Evaluation Unit

Australian and New Zealand Society of Nuclear Medicine

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10620-019-05781-6.pdf

Reference33 articles.

1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386.

2. Global Burden of Disease Liver Cancer. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015. JAMA Oncol. 2017;3:1683–1691.

3. Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391:1301–1314.

4. Goutte N, Sogni P, Bendersky N, et al. Geographical variations in incidence, management and survival of hepatocellular carcinoma in a Western country. J Hepatol. 2017;66:537–544.

5. Njei B, Rotman Y, Ditah I, Lim JK. Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology. 2015;61:191–199.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient Selection for Downstaging of Hepatocellular Carcinoma Prior to Liver Transplantation—Adjusting the Odds?;Transplant International;2022-04-21

2. Diagnostic Applications of Nuclear Medicine: Tumors of the Liver and Biliary Tract;Nuclear Oncology;2022

3. Diagnostic Applications of Nuclear Medicine: Tumors of the Liver and Biliary Tract;Nuclear Oncology;2022

4. Diagnostic Applications of Nuclear Medicine: Tumors of the Liver and Biliary Tract;Nuclear Oncology;2022

5. Molecular Imaging of Tumor Microenvironment to Assess the Effects of Locoregional Treatment for Hepatocellular Carcinoma;Hepatology Communications;2021-11-05